Clinical Trial Update: Janus Kinase Inhibition in Sarcoidosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating Janus kinase inhibition for sarcoidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Snippet

Sponsor: Yale University | Conditions: Sarcoidosis | Phase 2 | Status: COMPLETED